Contact Us

Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...

JelloX: Results of a Taiwan-based study are expected to be validated in a new collaboration with a major Japanese medical institution, assessing the higher sensitivity of 3D pathology over conventional sampling techniques across populations and...

Lunit: AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea, March 26,...